Financial Snapshot

Revenue
$10.39M
TTM
Gross Margin
48.2%
TTM
Net Earnings
-$9.524M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
74.31%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$4.715M
Q3 2024
Cash
Q3 2024
P/E
-0.3922
Nov 29, 2024 EST
Free Cash Flow
-$5.715M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018
Revenue $9.928M $10.40M $11.14M $8.184M $4.300M $4.390M
YoY Change -4.56% -6.58% 36.06% 90.33% -2.05%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018
Revenue $9.928M $10.40M $11.14M $8.184M $4.300M $4.390M
Cost Of Revenue $4.820M $4.757M $5.249M $3.585M $2.130M $2.360M
Gross Profit $5.108M $5.645M $5.886M $4.599M $2.170M $2.030M
Gross Profit Margin 51.45% 54.27% 52.86% 56.19% 50.47% 46.24%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018
Selling, General & Admin $9.891M $15.83M $8.036M $4.183M $5.900M $4.880M
YoY Change -37.52% 97.0% 92.12% -29.1% 20.9%
% of Gross Profit 193.64% 280.43% 136.52% 90.96% 271.89% 240.39%
Research & Development $1.619M $1.474M $295.3K $319.2K $160.0K $510.0K
YoY Change 9.86% 398.98% -7.5% 99.52% -68.63%
% of Gross Profit 31.69% 26.1% 5.02% 6.94% 7.37% 25.12%
Depreciation & Amortization $117.5K $22.43K $45.36K $44.76K $640.0K $470.0K
YoY Change 423.97% -50.54% 1.34% -93.01% 36.17%
% of Gross Profit 2.3% 0.4% 0.77% 0.97% 29.49% 23.15%
Operating Expenses $11.51M $15.83M $8.332M $4.502M $6.050M $5.390M
YoY Change -27.3% 90.02% 85.06% -25.59% 12.24%
Operating Profit -$11.17M -$10.19M -$5.925M -$2.406M -$3.880M -$3.360M
YoY Change 9.65% 71.91% 146.23% -37.98% 15.48%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018
Interest Expense $16.00K -$69.61K $2.103M $2.097M -$1.170M -$2.160M
YoY Change -122.99% -103.31% 0.28% -279.21% -45.83%
% of Operating Profit
Other Income/Expense, Net $69.86K $9.780K -$3.037M -$2.246M $170.0K $40.00K
YoY Change 614.33% -100.32% 35.22% -1421.0% 325.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018
Pretax Income -$11.10M -$10.25M -$8.962M -$4.650M -$4.880M -$5.470M
YoY Change 8.33% 14.33% 92.73% -4.71% -10.79%
Income Tax $0.00 $0.00 $0.00 -$160.0K -$130.0K
% Of Pretax Income
Net Earnings -$11.10M -$10.25M -$8.962M -$4.652M -$4.730M -$5.350M
YoY Change 8.33% 14.33% 92.64% -1.65% -11.59%
Net Earnings / Revenue -111.8% -98.5% -80.48% -56.84% -110.0% -121.87%
Basic Earnings Per Share -$1.23 -$1.16 -$2.09 -$4.97
Diluted Earnings Per Share -$1.23 -$1.16 -$2.09 -$4.97 -$775.4K -$877.0K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $5.006M $15.31M $27.74M $700.0K $50.00K $1.130M
YoY Change -67.3% -44.81% 3862.71% 1300.0% -95.58%
Cash & Equivalents
Short-Term Investments $2.662M
Other Short-Term Assets $292.1K $300.4K $327.0K $420.0K $80.00K $100.0K
YoY Change -2.78% -8.14% -22.13% 425.0% -20.0%
Inventory $50.00K $50.00K
Prepaid Expenses
Receivables $2.941M $3.926M $4.741M $2.180M $1.290M $1.030M
Other Receivables $0.00 $140.9K $140.9K $180.0K $100.0K $0.00
Total Short-Term Assets $8.239M $19.68M $32.95M $3.470M $1.580M $2.300M
YoY Change -58.13% -40.28% 849.52% 119.62% -31.3%
Property, Plant & Equipment $321.6K $410.5K $32.78K $80.00K $120.0K $150.0K
YoY Change -21.65% 1152.41% -59.03% -33.33% -20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $27.60K $27.60K $27.60K $30.00K $30.00K $30.00K
YoY Change 0.0% 0.0% -8.0% 0.0% 0.0%
Total Long-Term Assets $7.581M $4.942M $2.771M $2.740M $2.630M $1.740M
YoY Change 53.39% 78.33% 1.14% 4.18% 51.15%
Total Assets $15.82M $24.62M $35.72M $6.210M $4.210M $4.040M
YoY Change
Accounts Payable $3.925M $2.459M $832.7K $1.790M $740.0K $700.0K
YoY Change 59.63% 195.32% -53.48% 141.89% 5.71%
Accrued Expenses $1.708M $1.690M $1.018M $4.510M $2.220M $860.0K
YoY Change 1.07% 65.99% -77.43% 103.15% 158.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $11.99M $10.59M $6.970M
YoY Change -100.0% 13.22% 51.94%
Long-Term Debt Due $0.00 $600.0K
YoY Change -100.0%
Total Short-Term Liabilities $6.049M $4.281M $2.505M $22.14M $15.76M $11.30M
YoY Change 41.29% 70.88% -88.68% 40.48% 39.47%
Long-Term Debt $0.00 $0.00 $3.423M $180.0K $0.00 $0.00
YoY Change -100.0% 1801.46%
Other Long-Term Liabilities $29.13K $27.40K
YoY Change 6.31%
Total Long-Term Liabilities $29.13K $27.40K $3.423M $180.0K $0.00 $0.00
YoY Change 6.31% -99.2% 1801.46%
Total Liabilities $6.078M $4.308M $5.928M $22.31M $15.76M $11.30M
YoY Change 41.07% -27.32% -73.43% 41.56% 39.47%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 9.041M 8.844M 4.287M 936.2K
Diluted Shares Outstanding 9.041M 8.844M 4.287M 936.2K
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $3.735 Million

About iSpecimen Inc.

iSpecimen Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Lexington, Massachusetts and currently employs 53 full-time employees. The company went IPO on 2021-06-17. iSpecimen Inc. is a technology-driven company. The firm's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The firm's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

Industry: Services-Commercial Physical & Biological Research Peers: Better Therapeutics, Inc. BIOTRICITY INC. MediXall Group, Inc. Healthcare Triangle, Inc. HealthLynked Corp iCoreConnect Inc. NantHealth, Inc.